Medartis Holding AG (SWX:MED)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	955	770	1,038	972	1,538	548
Market Cap Growth	-25.88%	-25.88%	6.78%	-36.80%	180.86%	6.66%
Enterprise Value	937	763	1,051	988	1,479	485
Last Close Price	77.00	56.60	84.00	82.00	130.20	46.50
PE Ratio	275.00	218.11	1677.18	-	224.96	-
Forward PE	84.01	55.26	161.54	-	118.94	-
PS Ratio	4.25	3.42	4.90	5.32	9.62	4.29
PB Ratio	3.54	2.85	4.07	4.09	6.87	2.57
P/TBV Ratio	4.21	3.39	5.24	5.59	7.07	2.65
P/FCF Ratio	38.34	30.90	205.74	-	118.59	260.59
P/OCF Ratio	29.76	23.99	51.96	-	73.27	43.42
PEG Ratio	-	1.08	1.08	1.08	1.21	20.62
EV/Sales Ratio	4.17	3.40	4.96	5.40	9.25	3.80
EV/EBITDA Ratio	27.48	28.39	45.82	109.90	73.99	43.54
EV/EBIT Ratio	69.69	59.60	108.57	-	134.33	156.40
EV/FCF Ratio	37.63	30.66	208.20	-	114.06	230.63
Debt / Equity Ratio	0.45	0.45	0.11	0.12	0.11	0.13
Debt / EBITDA Ratio	3.62	3.62	0.93	1.88	0.94	1.67
Debt / FCF Ratio	4.87	4.87	5.43	-	1.86	12.93
Asset Turnover	0.56	0.56	0.63	0.58	0.55	0.45
Inventory Turnover	0.63	0.63	0.64	0.54	0.50	0.44
Quick Ratio	3.64	3.64	1.56	1.66	3.43	4.29
Current Ratio	5.21	5.21	3.08	3.49	5.06	6.28
Return on Equity (ROE)	1.34%	1.34%	0.25%	-2.50%	3.13%	-0.44%
Return on Assets (ROA)	1.98%	1.98%	1.79%	-0.37%	2.37%	0.68%
Return on Capital (ROIC)	2.38%	2.38%	2.21%	-0.46%	2.82%	0.80%
Return on Capital Employed (ROCE)	3.10%	3.10%	3.20%	-	4.20%	1.20%
Earnings Yield	0.37%	0.46%	0.06%	-0.60%	0.45%	-0.17%
FCF Yield	2.61%	3.24%	0.49%	-1.99%	0.84%	0.38%
Buyback Yield / Dilution	-1.10%	-1.10%	-3.69%	-0.29%	-0.27%	-0.24%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.